hypertension
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients who are treated with concomitant use of single hypertension drugs for 6 months or more 2)Patients who are treated with hypertension combination drug for 6 months or more, which includes same active ingredients treated in the previous concomitant use of single drugs
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of blood-pressure before and after switching concomitant use of single drugs to combination drug | — |
Countries
Japan
Contacts
Tokyo University of Science Faculty of Pharmaceutical Sciences